Institut National de la Santé et de la Recherche Médicale (INSERM);Institut Pasteur de Lille;National University of Ireland Maynooth
发明人:
Camille Locht,Bernard Mahon,Heather Kavanagh
申请号：
US15800921
公开号：
US20180085450A1
申请日:
2017.11.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a life attenuated Bordetella pertussis vaccine which is deficient for tracheal cytotoxin (TCT), pertussis toxin (PTX), and dermonecrotic toxin (DNT) for prophylaxis or treatment of an allergen-driven airway pathology.
